Investor

Alexandria Venture Investments

Last cheque observed Aug 2026; 126 cheques on record.

Deploying nowVC firm

Series AVentureSeries BBiotechnologyHealth Care

Deploying now
45%of best year13cheques in 12 months, 126 on record
Since the last cheque74days00hrs00min00sec
Median round$40MRounds led0 of 126Sole investor13 roundsMostly inUnited States, 92%
Pitch Alexandria Venture Investments

Alexandria Venture Investments highlights

  1. 01

    13 cheques in the last 12 months

  2. 02

    Mostly Series A and Venture: 63% of its rounds

  3. 03

    Sole investor in 13 rounds, median $12M

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Sectors
BiotechnologyHealth Care
Cold pitches
Not stated

The record

Every round we can evidence, newest first126 appearances

  1. 2026

    10 rounds

  2. Aug
    Khartis TherapeuticsSeries B · US · Ventureburn$50MWith 5 others
  3. Aug
    GeorgiamuneSeries B · US$93MWith 3 others
  4. Jun
    Vedana TherapeuticsSeries A · US$46MWith 1 other
  5. May
    CREATE MedicinesSeries B · US · Hatteras Venture Partners$122MWith 4 others
  6. May
    Autoimmunity BioSolutionsSeed · US$1.0MSole investor
  7. Apr
    Fathom TherapeuticsSeries A · US · AlleyWatch$47MWith 8 others
  8. Apr
    NeomorphSeries B · US · TechStartups$100MWith 4 others
  9. Apr
    KytopenVenture · USUndisclosedWith 2 others
  10. Jan
    Recludix PharmaVenture · USUndisclosedWith 2 others
  11. Jan
    TwoStep TherapeuticsSeries A · US$21MWith 2 others
  12. 2025

    23 rounds

  13. Nov
    Accipiter BiosciencesSeed · US · Columbus Venture Partners$13MWith 8 others
  14. Nov
    CrossBridge BioGrant · US$15MWith 1 other
  15. Nov
    Eclipse BioinnovationsVenture · US$4.9MSole investor
  16. Oct
    AeroRx TherapeuticsSeries A · US$21MWith 1 other
  17. Oct
    Tr1xVenture · US$50MSole investor
  18. Oct
    NILO TherapeuticsSeries A · US$101MWith 2 others
  19. Sept
    HAYA TherapeuticsVenture · CHUndisclosedWith 4 others
  20. Sept
    Crystalys TherapeuticsSeries A · US$205MWith 3 others
  21. Sept
    Dualitas TherapeuticsSeries A · US$65MWith 4 others
  22. Sept
    Thryv TherapeuticsVenture · CAUndisclosedWith 1 other
  23. Aug
    Leal TherapeuticsSeries A · US$30MWith 2 others
  24. Jul
    Dispatch BioSeries A · US$216MWith 1 other
  25. Jul
    Harpe BioDebt · US$975KWith 1 other
  26. Jun
    Arialys TherapeuticsVenture · US$15MSole investor
  27. Jun
    GeneCentric TherapeuticsSeries C · US$8.0MWith 2 others
  28. May
    Remedy Plan TherapeuticsVenture · US$18MSole investor
  29. Apr
    March BiosciencesGrant · US$200KWith 2 others
  30. Apr
    Hoofprint BiomeSeries A · US$15MWith 4 others
  31. Apr
    AIRNASeries B · US · LifeLink Ventures$155MWith 4 others
  32. Apr
    Solu TherapeuticsSeries A · US$41MWith 3 others
  33. Mar
    Stratus TherapeuticsSeries A$50MWith 2 others
  34. Mar
    Garuda TherapeuticsSeries A · US$50MWith 2 others
  35. Jan
    InariGrowth · US$144MWith 2 others
  36. 2024

    28 rounds

  37. Dec
    PlenoSeries B · US$25MWith 2 others
  38. Dec
    Ten63 TherapeuticsVenture · USUndisclosedWith 3 others
  39. Dec
    MeiogenixVenture · FRUndisclosedWith 4 others
  40. Nov
    CrossBridge BioSeed · US$10MSole investor
  41. Nov
    OverT BioGrant · US$120KWith 4 others
  42. Nov
    Autoimmunity BioSolutionsSeed · US$2.0MSole investor
  43. Nov
    Valora TherapeuticsSeed · US$30MWith 1 other

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 2 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Who they invest alongside

The investors most often in the same rounds as Alexandria Venture Investments. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies Alexandria Venture Investments put money into.

Quick answers about Alexandria Venture Investments

What does Alexandria Venture Investments invest in?

Alexandria Venture Investments invests most often at Series A and Venture (63% of the rounds on record), in sectors such as Biotechnology and Health Care.

How active is Alexandria Venture Investments?

126 investments on record, 13 of them in the last 12 months. The most recent was in Aug 2026.

What has Alexandria Venture Investments invested in recently?

Its most recent investments on record: Khartis Therapeutics (Series B, Aug 2026), Georgiamune (Series B, Aug 2026) and Vedana Therapeutics (Series A, Jun 2026).

How big are Alexandria Venture Investments's cheques?

The median round it joins is $40M.

Does Alexandria Venture Investments lead rounds?

Rarely, if at all: none of its 126 investments on record names it as the lead.

Where does Alexandria Venture Investments invest?

Most of the companies it backs are in the United States (92%).

Is Alexandria Venture Investments investing now?

Yes: it is actively investing, with 13 investments in the last 12 months.

Who does Alexandria Venture Investments invest alongside?

Most often ARCH Venture Partners (14 rounds together), Eli Lilly (12 rounds together) and Casdin Capital (10 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it